Cerebral Hemorrhage
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
PenumbraArtemis + Medical Management
TakedaCare bundle of active management
Clinical Trials (2)
Total enrollment: 7,303 patients across 2 trials
MIND: Artemis in the Removal of Intracerebral Hemorrhage
Start: Feb 2018Est. completion: Sep 2024236 patients
N/ACompleted
The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial
Start: Dec 2017Est. completion: Nov 20227,067 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space